American Healthcare REIT, Inc. (AHR) FinancialsAHRFinancialAmerican Healthcare REIT, Inc.

American Healthcare REIT, Inc. (AHR) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Private and other payors, accounting for 49.1% of total sales, equivalent to $311.65M. Other significant revenue streams include Medicare and Medicaid. Understanding this composition is critical for investors evaluating how AHR navigates market cycles within the Specialized REITs industry.

Evaluating the bottom line, American Healthcare REIT, Inc. maintains a gross margin of 18.48%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 6.71%, while the net margin is 4.59%. These profitability ratios, combined with a Return on Equity (ROE) of 3.96%, provide a clear picture of how effectively AHR converts its operational activities into shareholder value.

In the context of the broader market, AHR competes directly with industry leaders such as BXP and GLPI. With a market capitalization of $12.84B, it holds a leading position in the sector. When comparing efficiency, AHR's gross margin of 18.48% stands against BXP's 34.25% and GLPI's 95.93%. Such benchmarking helps identify whether American Healthcare REIT, Inc. is trading at a premium or discount relative to its financial performance.

AHR has demonstrated significant revenue growth, with total revenue increasing from $523.81 million in Q3 2024 to $674.25 million in Q2 2026. The normalized FFO per diluted share rose 28.6% year-over-year to $0.54 in Q2 2026, indicating strong operational performance.